Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiebai San Granules
- Development stage
- Unknown
- Lead developer
- Kangyuan Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xiebai San Granules is a traditional Chinese medicine (TCM) compound preparation classified as a Class 3.1 classic prescription drug. Originating from the Song-dynasty text *Xiao Er Yao Zheng Zhi Jue* by Qian Yi, the formula consists of four main herbal ingredients: stir-fried mulberry bark (Sang Bai Pi), baked lycium bark (Di Gu Pi), stir-fried licorice root (Gan Cao), and rice (Jing Mi). It is traditionally used to clear heat from the lungs, relieve cough, and alleviate wheezing, particularly for pediatric lung-heat cough and asthma patterns. Developed by Jiangsu Kangyuan Pharmaceutical, Xiebai San Granules was approved by China's National Medical Products Administration (NMPA) in December 2025 for the treatment of pediatric lung-heat cough and asthma syndrome.
- Other names
- Xie Bai SanXie Bai San GranulesXiebai San泻白散泻白散颗粒
Beyond the preview
Go deeper on Xiebai San Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiebai San Granules.